Literature DB >> 19645613

The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer.

I Ross McDougall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19645613     DOI： 10.1089/thy.2009.1582

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  4 in total

1.  To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy.

Authors:  Sandy Srinivas; Andrei Iagaru
Journal:  J Nucl Med       Date:  2021-08-26       Impact factor: 10.057

2.  Clinical significance of observation without repeated radioiodine therapy in differentiated thyroid carcinoma patients with positive surveillance whole-body scans and negative thyroglobulin.

Authors:  Dong-Jun Lim; Joo Hyun O; Min-Hee Kim; Ji-Hyun Kim; Hyuk-Sang Kwon; Sung-Hoon Kim; Moo-Il Kang; Bong-Yun Cha; Kwang-Woo Lee; Ho-Young Son
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 2.884

3.  Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer.

Authors:  Seunggyun Ha; So Won Oh; Yu Kyeong Kim; Do Hoon Koo; Young Ho Jung; Ka Hee Yi; June-Key Chung
Journal:  J Korean Med Sci       Date:  2015-06-10       Impact factor: 2.153

4.  Added Value of Postoperative Radioiodine Scan for Staging and Risk Stratification in Papillary Thyroid Microcarcinoma.

Authors:  Tawika Kaewchur; Sirianong Namwongprom; Nipawan Waisayanand; Waralee Pongwiwattanachai; Molrudee Ekmahachai
Journal:  J ASEAN Fed Endocr Soc       Date:  2021-04-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.